Drugs & Targets FDA issues warning letters to breast implant manufacturers to deliver on post-approval requirements March 22, 2019Vol.45 No.12
Drugs & Targets European Commission approves Keytruda + chemotherapy for NSCLC March 15, 2019Vol.45 No.11
Drugs & Targets Tecentriq + Abraxane regimen gets accelerated approval for breast cancer March 15, 2019Vol.45 No.11
Drugs & Targets Lynparza receives positive EU CHMP opinion in breast cancer March 08, 2019Vol.45 No.10
